Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers
CA 2497554 A1 · Owner: Dendreon Corporation · Inventors: Gold, Mitchell; Pickering, Grant; Peshwa, Madhusudan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Provided are immunotherapeutic compositions and methods for the treatment of cancers characterized by the presence of moderately to well-differentiated cancer cells. Exemplary immunotherapeutic compositions employ antigen presenting cells, including dendritic cells activated by a protein conjugate , such as fusion proteins including a prostatic acid phosphatase/granulocytemacrophage colony stimulation factor fusion protein. Also disclosed are methods for assessing the susceptibility of cancer cells to treatment regimens employing one or more immunotherapeutic composition.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 19, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 19, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 19, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.